These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38707016)

  • 1. Unraveling the Paradox: Can Anticoagulation Improve Outcomes in Patients With Heart Failure and Increased Bleeding Risk?
    Saeed D; Fuenmayor D; Niño Medina JA; Saleh I; Castiblanco Torres JD; Horn WL; Sosa Quintanilla MH; Leiva KE; Dannuncio V; Viteri M; Rivas M; Kumari N
    Cureus; 2024 Apr; 16(4):e57544. PubMed ID: 38707016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood Coagulation Disorders in Heart Failure: From Basic Science to Clinical Perspectives.
    Siniarski A; Gąsecka A; Borovac JA; Papakonstantinou PE; Bongiovanni D; Ehrlinder H; Giustozzi M; Guerreiro RA; Parker WAE
    J Card Fail; 2023 Apr; 29(4):517-526. PubMed ID: 36632933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrupted versus uninterrupted anticoagulation therapy for catheter ablation in adults with arrhythmias.
    Bawazeer GA; Alkofide HA; Alsharafi AA; Babakr NO; Altorkistani AM; Kashour TS; Miligkos M; AlFaleh KM; Al-Ansary LA
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013504. PubMed ID: 34674223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation Therapy and NOACs in Heart Failure.
    Thomas I; EncisoSilva J; Schlueter M; Greenberg B
    Handb Exp Pharmacol; 2017; 243():515-535. PubMed ID: 28233177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained atrial fibrillation increases the risk of anticoagulation-related bleeding in heart failure.
    Prochaska JH; Göbel S; Nagler M; Knöpfler T; Eggebrecht L; Lamparter H; Panova-Noeva M; Keller K; Coldewey M; Bickel C; Lauterbach M; Hardt R; Espinola-Klein C; Ten Cate H; Rostock T; Münzel T; Wild PS
    Clin Res Cardiol; 2018 Dec; 107(12):1170-1179. PubMed ID: 29948286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of patients with atrial fibrillation on oral anticoagulation with and without heart failure: the ETNA-AF-Europe registry.
    Schnabel RB; Ameri P; Siller-Matula JM; Diemberger I; Gwechenberger M; Pecen L; Manu MC; Souza J; De Caterina R; Kirchhof P
    Europace; 2023 Aug; 25(9):. PubMed ID: 37713182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes and factors associated with mortality in patients with atrial fibrillation and heart failure: FARAONIC study.
    Gómez Doblas JJ; Cepeda-Rodrigo JM; Agra Bermejo R; Blanco Labrador E; Blasco MT; Carrera Izquierdo M; Lekuona I; Recio Mayoral A; Rafols C; Manito N
    Clin Cardiol; 2023 Nov; 46(11):1390-1397. PubMed ID: 37596723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation in heart failure without atrial fibrillation: gaps and dilemmas in current clinical practice.
    Siliste RN; Antohi EL; Pepoyan S; Nakou E; Vardas P
    Eur J Heart Fail; 2018 Jun; 20(6):978-988. PubMed ID: 29504188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.
    Shantsila E; Lip GY
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD003333. PubMed ID: 27629776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes and anticoagulation therapy in elderly non-valvular atrial fibrillation and heart failure patients.
    Ikeda S; Hiasa KI; Inoue H; Yamashita T; Akao M; Atarashi H; Koretsune Y; Okumura K; Shimizu W; Suzuki S; Ikeda T; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Morishima Y; Takita A; Tsutsui H
    ESC Heart Fail; 2024 Apr; 11(2):902-913. PubMed ID: 38213104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the Dilemma: Anticoagulation for Heart Failure With Preserved Ejection Fraction (HFpEF).
    Jyotsna F; Mahfooz K; Sohail H; Kumar S; Adeeb M; Anand D; Kumar R; Rekha F; Varrassi G; Khatri M; Kumar S
    Cureus; 2023 Aug; 15(8):e43279. PubMed ID: 37692595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke and Thromboembolism in Patients with Heart Failure and Sinus Rhythm: A Matter of Risk Stratification?
    Rivas A; Lauw MN; Schnabel RB; Crowther M; Van Spall HGC
    Thromb Haemost; 2022 Jun; 122(6):871-878. PubMed ID: 35045579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation versus placebo for heart failure in sinus rhythm.
    Shantsila E; Kozieł M; Lip GY
    Cochrane Database Syst Rev; 2021 May; 5(5):CD003336. PubMed ID: 34002371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks of Heart Failure, Stroke, and Bleeding in Atrial Fibrillation According to Heart Failure Phenotypes.
    Inciardi RM; Giugliano RP; Park JG; Nordio F; Ruff CT; Chen C; Lanz HJ; Antman EM; Braunwald E; Solomon SD
    JACC Clin Electrophysiol; 2023 Apr; 9(4):569-580. PubMed ID: 37100536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy.
    Siller-Matula JM; Pecen L; Patti G; Lucerna M; Kirchhof P; Lesiak M; Huber K; Verheugt FWA; Lang IM; Renda G; Schnabel RB; Wachter R; Kotecha D; Sellal JM; Rohla M; Ricci F; De Caterina R;
    Int J Cardiol; 2018 Aug; 265():141-147. PubMed ID: 29706429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with disease progression in patients with atrial fibrillation and heart failure anticoagulated with rivaroxaban.
    Manito N; Cepeda-Rodrigo JM; Farré N; Castillo Orive M; Galve E; Jiménez-Candil J; García-Pinilla JM; López Sánchez ES; Rafols C; Gómez Doblas JJ
    Clin Cardiol; 2024 Feb; 47(2):e24189. PubMed ID: 38018889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.
    Lip GY; Piotrponikowski P; Andreotti F; Anker SD; Filippatos G; Homma S; Morais J; Pullicino P; Rasmussen LH; Marín F; Lane DA;
    Thromb Haemost; 2012 Dec; 108(6):1009-22. PubMed ID: 23093044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Heart Failure Type on Thromboembolic and Bleeding Risk in Patients With Atrial Fibrillation on Oral Anticoagulation.
    Mentias A; Briasoulis A; Shantha G; Alvarez P; Vaughan-Sarrazin M
    Am J Cardiol; 2019 May; 123(10):1649-1653. PubMed ID: 30928033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.
    Lip GY; Ponikowski P; Andreotti F; Anker SD; Filippatos G; Homma S; Morais J; Pullicino P; Rasmussen LH; Marin F; Lane DA;
    Eur J Heart Fail; 2012 Jul; 14(7):681-95. PubMed ID: 22611046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation in heart failure: current status and future direction.
    Gheorghiade M; Vaduganathan M; Fonarow GC; Greene SJ; Greenberg BH; Liu PP; Massie BM; Mehra MR; Metra M; Zannad F; Cleland JG; van Veldhuisen DJ; Shah AN; Butler J
    Heart Fail Rev; 2013 Nov; 18(6):797-813. PubMed ID: 22987320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.